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O’Donnell and colleagues cite studies purporting to show increased mortality with low 
sodium intake, but many studies of sodium and health outcomes are deeply flawed by 
measurement error, confounding, and reverse causality.1 For studies of cardiovascular 
disease outcomes, long-term diet, rather than intake on a single day or a small number of 
days, is the relevant measure of sodium intake.2 Urinary sodium excretion varies enormously 
throughout the day, from day to day, and according to diet, medications, chronic diseases, 
and hormonal fluctuations; only multiple, complete, 24-hour urine samples accurately reflect 
the usual sodium intake in an individual person.1,2 Estimates of 24-hour sodium excretion 
that are based on spot urine samples, and therefore the apparent association between 
cardiovascular disease outcomes and spot urine samples, can be substantially biased.3 
Analysis without multiple 24-hour urine samples inaccurately categorizes sodium intake for 
many persons and contributes to an ostensible but invalid J-shaped association with 
cardiovascular disease in individual studies or in meta-analyses such as that cited by 
Alderman. In contrast, the use of multiple 24-hour urine collections indicates a positive and 
linear, not J-shaped, association with total mortality across a broad range of sodium intake, 
including among participants whose usual sodium intake was less than 2300 mg per day.4
In response to O’Donnell et al. and Graudal: the combination of trials with widely varying 
levels and durations of intended or achieved reduction in sodium intake may bias results. 
Clinical trials typically analyze sodium exposure on the basis of the intention-to-treat 
principle; if participants do not meet target reductions (e.g., because the food environment 
makes low sodium consumption extremely difficult), results are biased toward the null. Also, 
extreme, rapid reductions (e.g., down to levels below physiologic need, <500 mg) do not 
reflect the effects of long-term, moderate population-wide reductions in sodium intake such 
as those proposed by the Food and Drug Administration. According to a Cochrane review of 
34 randomized trials involving normotensive participants and hypertensive participants, 
moderate and longer-term (>4 weeks) reduction in sodium intake, down to less than 1500 
mg daily, significantly lowers blood pressure in a linear dose–response relationship; the 
effects on the renin–angiotensin–aldosterone system are small and within the expected 
physiologic range.5 In a meta-analysis of long-term randomized trials, the effects of average 
reductions of 400 to 1200 mg in daily sodium intake significantly reduce the risk of 
cardiovascular events by 20% among normotensive participants and hypertensive 
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participants combined, with a reduction of similar magnitude, albeit with inadequate sample 
size to show statistical significance, among the subgroup of normotensive participants.6
In response to O’Donnell et al., Alderman, and Johns: Hill’s causal criteria focused on 
occupational hazards and preventive medicine and included examples that were related to 
cigarette smoking and diet. Hill stated that requiring strong evidence “does not imply 
crossing every ‘t’ and swords with every critic, before we act.” He concluded that “all 
scientific work is incomplete — whether it be observational or experimental” and 
emphasized not ignoring the knowledge we have. A general population trial to determine 
cardiovascular outcomes is impractical, because it would require tens of thousands of 
persons to maintain intended dietary sodium levels for many years.6
The 2013 IOM committee concluded, “Although the reviewed evidence on associations 
between sodium intake and direct health outcomes has methodological flaws and limitations 
… when considered collectively, it indicates a positive relationship between higher levels of 
sodium intake and CVD risk. This evidence is consistent with existing evidence on blood 
pressure as a surrogate indicator of CVD risk.” To correct misinterpretation, the IOM 
committee chair wrote, “Rather than focusing on disagreements about specific targets that 
currently affect less than 10% of the U.S. population (i.e., sodium intake of <2,300 mg/d vs. 
<1,500 mg/d), the IOM, AHA, WHO, and DGA [Dietary Guidelines for Americans] are 
congruent in suggesting that excess sodium intake should be reduced.” The 2015 Dietary 
Guidelines Advisory Committee, noting general population goals of less than 2300 mg of 
sodium per day, concluded that the totality of evidence of a cardiovascular benefit from 
limiting dietary sodium is strong and encouraged the food industry to reduce the amount of 
sodium added to foods in order to support healthy dietary choices.
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